Detalles de la búsqueda
1.
A phase 1 safety and bioimaging trial of antibody DS-8895a against EphA2 in patients with advanced or metastatic EphA2 positive cancers.
Invest New Drugs
; 40(4): 747-755, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35404015
2.
Phase II study of everolimus (RAD001) monotherapy as first-line treatment in advanced biliary tract cancer with biomarker exploration: the RADiChol Study.
Br J Cancer
; 118(7): 966-971, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29527009
3.
Digital PCR of Genomic Rearrangements for Monitoring Circulating Tumour DNA.
Adv Exp Med Biol
; 924: 139-146, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27753035
4.
Global protein profiling reveals anti-EGFR monoclonal antibody 806-modulated proteins in A431 tumor xenografts.
Growth Factors
; 31(5): 154-64, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23957735
5.
Villin expression is frequently lost in poorly differentiated colon cancer.
Am J Pathol
; 180(4): 1509-21, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22349300
6.
Sox9 drives columnar differentiation of esophageal squamous epithelium: a possible role in the pathogenesis of Barrett's esophagus.
Am J Physiol Gastrointest Liver Physiol
; 303(12): G1335-46, 2012 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23064761
7.
Paracrine IL-6 Signaling Confers Proliferation between Heterogeneous Inflammatory Breast Cancer Sub-Clones.
Cancers (Basel)
; 14(9)2022 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35565421
8.
Expression of EGFR and conformational forms of EGFR in malignant pleural mesothelioma and its impact on survival.
Lung Cancer
; 153: 35-41, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33453471
9.
Analysis of angiogenic and stromal biomarkers in a large malignant mesothelioma cohort.
Lung Cancer
; 150: 1-8, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33035778
10.
Mesenchyme to epithelial transition protein expression, gene copy number and clinical outcome in a large non-small cell lung cancer surgical cohort.
Transl Lung Cancer Res
; 8(2): 167-175, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31106127
11.
A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen.
Clin Cancer Res
; 13(11): 3286-92, 2007 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17545534
12.
Metabolic response evaluation for colorectal liver metastases and correlation to pathologic response and tumour markers.
ANZ J Surg
; 88(3): E108-E113, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27452367
13.
Development of monoclonal anti-PDGF-CC antibodies as tools for investigating human tissue expression and for blocking PDGF-CC induced PDGFRα signalling in vivo.
PLoS One
; 13(7): e0201089, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30052660
14.
Author Correction: DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis.
Sci Rep
; 13(1): 2422, 2023 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36765160
15.
DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis.
Sci Rep
; 8(1): 1767, 2018 01 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-29379130
16.
The Immune Microenvironment, Genome-wide Copy Number Aberrations, and Survival in Mesothelioma.
J Thorac Oncol
; 12(5): 850-859, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28257959
17.
Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies.
J Nucl Med
; 47(3): 410-8, 2006 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-16513609
18.
Lack of correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in non-small cell lung cancer assessed by 18F-Fluoromisonidazole and 18F-FDG PET.
J Nucl Med
; 47(12): 1921-6, 2006 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17138734
19.
Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity.
Clin Cancer Res
; 11(17): 6390-9, 2005 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16144944
20.
A phase I trial of humanized monoclonal antibody A33 in patients with colorectal carcinoma: biodistribution, pharmacokinetics, and quantitative tumor uptake.
Clin Cancer Res
; 11(13): 4810-7, 2005 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16000578